PhaseBio Pharmaceuticals, Inc. (PHAS)
R&D Expenses
$20.94M
Quarterly · Period ending: · USD
PHAS R&D Expenses
Latest reported$20.94Mperiod ending
Latest reported$20.94Mperiod ending
PHAS Quarterly R&D Expenses ($1.33M → $20.94M)
Quarterly R&D Expenses
High-resolution chart · PNG
PHAS r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 20,939,000 | |
| 14,336,000 | |
| -74,649,893 | |
| 25,066,000 | |
| 27,366,000 | |
| 22,320,000 | |
| 22,367,000 | |
| 17,416,000 | |
| 20,856,000 | |
| 11,449,000 | |
| 8,381,000 | |
| 9,028,000 | |
| 7,781,000 | |
| 5,721,000 | |
| 5,676,000 | |
| 4,354,000 | |
| 3,190,000 | |
| 2,235,000 | |
| 1,823,000 | |
| 1,330,000 |